Live Quote · NASDAQDSGNHealthcare· Biotechnology

Design Therapeutics, Inc.

$9.02▼ 3.22%($-0.30)
MKT CAP $577.61MNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
39/100
▌ Weak
47
Valuation
20
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DSGN research report →

Analyst Price Target
$26.00+188.2% vs. today

Range $26 – $26

Analyst RatingBuy
4 Buy3 Hold0 Sell

Price Chart

+14.61% · this period
$15.94$11.90$7.87Nov 20May 26Nov 20
52-Week Range13% of range
Low
$7.82
Current
$9.02
High
$17.25